How ICER’s Missteps Leave Access in Doubt For Atopic Dermatitis Patients
April 24, 2017
The Institute for Clinical and Economic Review finds new treatments for atopic dermatitis to be cost effective – justifying health plan coverage for the medications. But methodological missteps invite questions about how secure patients’ access to the treatments will be.
Categorized in: Analysis